Popular Articles

Dr. Reddy's Receives Approval For Three INDs And Announces Reorganization Of Its Drug Discovery Operations
Dr. Reddy"s announced that the first human subjects were successfully dosed in a phase I study with DRL 17822, a selective inhibitor of CETP, for the treatment of dyslipidemia, atherosclerosis and associated cardiovascular diseases. The compound shows potent elevation in HDL-C and reduction of atherosclerotic plaques in animals, and has a clean safety profile in preclinical studies. The two other IND"s are for the treatment of COPD and dyslipidemia.

Antibiotic Prescribing Should Be Standardized Across Europe To Help Tackle Resistance
Antibiotic prescribing for respiratory illnesses should be standardised across Europe to help reduce inappropriate prescribing and resistance, say experts in a study published on bmj.com.
News of the day
News From The American Chemical Society, June 24, 2009
Potential new drugs: 970 million and still counting
Oncology

PIH Founder Farmer Discussing Possible Appointment To Coordinate U.S. Global Health Initiatives, Boston Globe Reports

Paul Farmer -- founder of Partners in Health and vice chair of the Department of Global Health and Social Medicine at Harvard Medical School -- said he is in discussions with the State Department about a possible Obama administration appointment to coordinate U.S. global health initiatives, the Boston Globe reports. Farmer made the announcement Monday during a meeting with HMS faculty. Farmer said that he has not decided whether he will accept the appointment if he receives a formal offer but that he is considering it, according to the Globe. The Globe reports that it was unable to confirm whether Farmer is being considered for a full-time policy position or for an advisory role or if the appointment would be a new or existing position. Several top positions at USAID -- including administrator, deputy administrator and the assistant administrator in charge of global health are vacant, the Globe reports. These positions are presidential appointments and would require Senate confirmation. In addition, Farmer could be discussing health policy positions with the State Department. Farmer did not respond for requests seeking comment. PIH and HMS also declined comment. A spokesperson at the State Department would not discuss personnel discussions that are in progress or possible new positions. Laurie Garrett, a global health policy specialist at the Council on Foreign Relations, said the administration"s announcement last week of a $63 billion, six-year initiative that aims to address HIV/AIDS, tuberculosis, malaria and other illnesses could allow new appointees the opportunity to make a significant impact in U.S. global health policy. Garrett, who has known Farmer for several years, added that she would be surprised if he is considering a government position in part because of his extensive involvement with PIH (Smith, Boston Globe, 5/15). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):